Benjamin Harshbarger - 08 Jun 2021 Form 4 Insider Report for CATABASIS PHARMACEUTICALS INC (ATXS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATXS	Stock Option (right to buy)	Award	$0	+200,000		$0.000000	200,000	08 Jun 2021	Common Stock	200,000	$2.16	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2021 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.